Found: 29
Select item for more details and to access through your institution.
Moving away from chemotherapy in newly diagnosed Philadelphia chromosome‐positive B‐cell acute lymphoblastic leukaemia.
- Published in:
- British Journal of Haematology, 2023, v. 202, n. 6, p. 1084, doi. 10.1111/bjh.19012
- By:
- Publication type:
- Article
A phase 2 trial of mini‐hyper‐CVD, blinatumomab, and ponatinib in Philadelphia positive acute lymphoblastic leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 11, p. 2229, doi. 10.1002/ajh.27463
- By:
- Publication type:
- Article
Ponatinib‐review of historical development, current status, and future research.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 8, p. 1576, doi. 10.1002/ajh.27355
- By:
- Publication type:
- Article
Characteristics and outcomes of patients with relapsed Philadelphia chromosome‐positive acute lymphoblastic leukemia after failure of a frontline ponatinib‐containing therapy.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 7, p. 1423, doi. 10.1002/ajh.27329
- By:
- Publication type:
- Article
The presence of additional cytogenetic abnormalities (ACAs) or Philadelphia chromosome variants do not adversely affect the achievement of treatment‐free remission in chronic myeloid leukemia.
- Published in:
- American Journal of Hematology, 2024, v. 99, n. 6, p. 1175, doi. 10.1002/ajh.27307
- By:
- Publication type:
- Article
Treatment discontinuation in chronic myeloid leukemia: When, how, and why?
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 11, p. 1670, doi. 10.1002/ajh.27100
- By:
- Publication type:
- Article
Characteristics and outcomes of patients with chronic myeloid leukemia and T315I mutation treated in the pre‐ and post‐ponatinib era.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 10, p. 1619, doi. 10.1002/ajh.27037
- By:
- Publication type:
- Article
Ultrasensitive NGS MRD assessment in Ph+ ALL: Prognostic impact and correlation with RT‐PCR for BCR::ABL1.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 8, p. 1196, doi. 10.1002/ajh.26949
- By:
- Publication type:
- Article
The outcomes of patients with chronic myeloid leukemia treated with third‐line BCR::ABL1 tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 4, p. 658, doi. 10.1002/ajh.26852
- By:
- Publication type:
- Article
Frontline combination of ponatinib and hyper‐CVAD in Philadelphia chromosome‐positive acute lymphoblastic leukemia: 80‐months follow‐up results.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. 493, doi. 10.1002/ajh.26816
- By:
- Publication type:
- Article
Common kinase mutations do not impact optimal molecular responses in core binding factor acute myeloid leukemia treated with fludarabine, cytarabine, and G‐CSF based regimens.
- Published in:
- American Journal of Hematology, 2023, v. 98, n. 3, p. E53, doi. 10.1002/ajh.26811
- By:
- Publication type:
- Article
Low‐dose dasatinib 50 mg/day versus standard‐dose dasatinib 100 mg/day as frontline therapy in chronic myeloid leukemia in chronic phase: A propensity score analysis.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 11, p. 1413, doi. 10.1002/ajh.26689
- By:
- Publication type:
- Article
Treatment‐free remission in patients with chronic myeloid leukemia following the discontinuation of tyrosine kinase inhibitors.
- Published in:
- American Journal of Hematology, 2022, v. 97, n. 7, p. 856, doi. 10.1002/ajh.26550
- By:
- Publication type:
- Article
PD-L1 protein expression by Combined Positive Score (CPS) in patients with muscle invasive or advanced urothelial carcinoma: a single institution experience.
- Published in:
- BMC Cancer, 2023, v. 23, n. 1, p. 1, doi. 10.1186/s12885-023-11299-y
- By:
- Publication type:
- Article
Treatment de-escalation in Philadelphia chromosome–positive B-cell acute lymphoblastic leukemia: the emerging role of chemotherapy-free regimens.
- Published in:
- Therapeutic Advances in Hematology, 2023, v. 14, p. 1, doi. 10.1177/20406207231151294
- By:
- Publication type:
- Article
Influences on story development in transnational pan-Arab dramas: A case study of the series 04.
- Published in:
- Journal of Screenwriting, 2019, v. 10, n. 2, p. 179, doi. 10.1386/josc.10.2.179_1
- By:
- Publication type:
- Article
Using Proton Pump Inhibitors is not Associated With Adverse Outcomes in Patients With Chronic Myeloid Leukemia Treated With Dasatinib.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 7, p. 484, doi. 10.1016/j.clml.2024.02.014
- By:
- Publication type:
- Article
SOHO State of the Art Updates and Next Questions | Next Questions: Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 6, p. 333, doi. 10.1016/j.clml.2023.12.013
- By:
- Publication type:
- Article
Dose-Dense Mini-Hyper-CVD, Inotuzumab Ozogamicin and Blinatumomab Achieves Rapid MRD-Negativity in Philadelphia Chromosome-Negative B-cell Acute Lymphoblastic Leukemia.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2024, v. 24, n. 4, p. e168, doi. 10.1016/j.clml.2023.12.016
- By:
- Publication type:
- Article
Low-Dose Dasatinib (50 mg Daily) Frontline Therapy in Newly Diagnosed Chronic Phase Chronic Myeloid Leukemia: 5-Year Follow-Up Results.
- Published in:
- Clinical Lymphoma, Myeloma & Leukemia, 2023, v. 23, n. 10, p. 742, doi. 10.1016/j.clml.2023.05.009
- By:
- Publication type:
- Article
Results of salvage therapy with mini-hyper-CVD and inotuzumab ozogamicin with or without blinatumomab in pre-B acute lymphoblastic leukemia.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01444-2
- By:
- Publication type:
- Article
The evolution of acute lymphoblastic leukemia research and therapy at MD Anderson over four decades.
- Published in:
- Journal of Hematology & Oncology, 2023, v. 16, n. 1, p. 1, doi. 10.1186/s13045-023-01409-5
- By:
- Publication type:
- Article
Outcome of 3q26.2/MECOM rearrangements in chronic myeloid leukemia.
- Published in:
- International Journal of Hematology, 2024, v. 120, n. 2, p. 203, doi. 10.1007/s12185-024-03787-z
- By:
- Publication type:
- Article
Netflix speaks Arabic, Arabs speak Netflix: How SVOD is transforming Arabic series screenwriting.
- Published in:
- Journal of Arab & Muslim Media Research, 2021, v. 14, n. 2, p. 261, doi. 10.1386/jammr_00034_1
- By:
- Publication type:
- Article
Results of ponatinib as frontline therapy for chronic myeloid leukemia in chronic phase.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 19, p. 3344, doi. 10.1002/cncr.35384
- By:
- Publication type:
- Article
Combination of dasatinib and venetoclax in newly diagnosed chronic phase chronic myeloid leukemia.
- Published in:
- Cancer (0008543X), 2024, v. 130, n. 15, p. 2652, doi. 10.1002/cncr.35317
- By:
- Publication type:
- Article
Outcome of Philadelphia chromosome‐positive chronic myeloid leukemia in the United States since the introduction of imatinib therapy—The Surveillance, Epidemiology, and End Results database, 2000–2019.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 23, p. 3805, doi. 10.1002/cncr.35038
- By:
- Publication type:
- Article
Reply to "Impact of obesity surgery on tyrosine kinase inhibitor responses and survival outcomes in patients with chronic myeloid leukemia: Further data are still warranted!".
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 14, p. 2268, doi. 10.1002/cncr.34834
- By:
- Publication type:
- Article
Association between bariatric surgery and outcomes in chronic myeloid leukemia.
- Published in:
- Cancer (0008543X), 2023, v. 129, n. 12, p. 1866, doi. 10.1002/cncr.34725
- By:
- Publication type:
- Article